Back to Market Feed

ACTEMRA ACTPEN 162 MG/0.9 ML

$1279.0600per ML

Strength

162 mg/.9mL

Manufacturer

Genentech, Inc.

NDC

50242014301

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

11/19/2018

Pharmacological Classes

Interleukin 6 Receptor Antagonists

Interleukin-6 Receptor Antagonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

+0.4%

Generic Alternatives

Save up to 22%

1 alternative • Same active ingredient

ACTEMRA 162 MG/0.9 ML SYRINGE

50242013801•Genentech, Inc.

Related Drugs

Same classification

KEVZARA 200 MG/1.14 ML SYRINGE

00024591001•Sanofi-Aventis U.S. LLC

KEVZARA 200 MG/1.14 ML PEN INJ

00024592201•Sanofi-Aventis U.S. LLC